Regimmune raises $9.2 million in series D

Autoimmune and allergy company Regimmune Corp. (Tokyo, Japan) raised $9.2 million in a series D round led by Japan Asia Investment and Nippon Venture Capital. New investors Mizuho Capital; Nissei Insu...